1T-LSD
1T-LSD[edit | edit source]
1T-LSD is a psychedelic compound that is structurally related to lysergic acid diethylamide (LSD). It is part of a class of substances known as lysergamides, which are derivatives of lysergic acid. 1T-LSD is known for its psychoactive effects, which are similar to those of LSD, but it is distinguished by the presence of a thiophene ring in its chemical structure.
Chemical Structure[edit | edit source]
1T-LSD is chemically known as 1-thiophene-N,N-diethyllysergamide. The presence of the thiophene ring is a key differentiator from LSD, which contains an indole ring. This modification is believed to alter the compound's interaction with serotonin receptors in the brain, potentially leading to differences in its psychoactive effects.
Pharmacology[edit | edit source]
1T-LSD acts primarily as a partial agonist at the 5-HT2A receptor, which is the main target for classical psychedelics. The interaction with this receptor is responsible for the hallucinogenic effects experienced by users. Like other lysergamides, 1T-LSD may also interact with other serotonin receptor subtypes, contributing to its complex effects on perception, mood, and cognition.
Effects[edit | edit source]
The effects of 1T-LSD are similar to those of LSD, including altered sensory perception, changes in mood, and cognitive shifts. Users may experience visual hallucinations, a sense of euphoria, and altered time perception. The onset of effects typically occurs within 30 to 60 minutes after ingestion, with a duration of action lasting 6 to 12 hours.
Legal Status[edit | edit source]
The legal status of 1T-LSD varies by country. In some jurisdictions, it may be classified as a controlled substance due to its structural similarity to LSD and its psychoactive properties. In others, it may not be specifically scheduled, although it could still be subject to analogue laws that regulate substances similar to controlled drugs.
Related Compounds[edit | edit source]
1T-LSD is part of a broader class of lysergamides, which includes other compounds such as 1P-LSD, ALD-52, and ETH-LAD. These compounds share a common lysergic acid backbone but differ in their substituents, leading to variations in their pharmacological profiles and effects.
See Also[edit | edit source]
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD